USA TODAY International Edition

Opioid fears cause more pain, suffering for patients

- Dr. Jeffrey A. Singer Cato Institute and Josh Bloom American Council on Science and Health

A decade ago, most people thought of Tylenol ( acetaminop­hen) as a medicine for fever, malaise and minor aches and pains.

Nobody imagined that it would become the go- to drug for treating moderate, let alone severe, postoperat­ive pain.

But this is just what has happened. Thanks to pressure from lawmakers, government agencies and policymake­rs who inserted themselves into the patient- doctor relationsh­ip, patients became the victims of the never- ending war on drugs.

Now, doctors frequently offer only acetaminop­hen to treat painful conditions despite the drug’s inability to remedy them.

Doctors pressured into ‘ opioid- sparing protocols’

Policymake­rs’ exaggerate­d fear of opioids has pressured hospitals, doctors and dentists to switch to acetaminop­hen, no matter how severe the patient’s pain.

Sometimes, the drug is given intravenou­sly in high doses as part of “opioidspar­ing protocols.”

We believe that using the drug in this way is ill- advised, cruel and borders on malpractic­e.

Lawmakers believed they had to do something about the opioid overdose crisis, which has grown exponentia­lly since the 1970s. The crisis was driven by a growing population of nonmedical drug users accessing drugs from the black market.

Now, nearly 40 states have passed laws dictating the maximum number and dose of opioids that doctors are permitted to prescribe to their patients, all based on the misguided notion that medical use of prescripti­on pain pills caused the crisis.

But what’s really fueling overdose deaths is drug prohibitio­n and the dangerous black market that it creates. The Centers for Disease Control and Prevention got into the act by guiding doctors in treating pain, an area not in the agency’s wheelhouse.

The evidence clearly shows that acetaminop­hen alone is a poor choice for treating most types of pain.

Multiple literature reviews show that the drug has limited analgesic utility. Several Cochrane systematic reviews, which are highly regarded, evidenceba­sed analyses that carefully evaluate the quality of data in numerous studies, have questioned its ability to relieve pain caused by a variety of conditions. With few exceptions, it fails miserably.

For example, studies reveal that acetaminop­hen effectively reduces fever in children.

But, while the drug is frequently recommende­d for headache pain, its efficacy is mostly imaginary.

A 2016 Cochrane review examined 23 studies, including more than 8,000 people with tension headaches. And though nearly 60% of the participan­ts experience­d relief within two hours, so did half of the group that received a placebo.

The authors concluded, “Only 10% people with tension- type headaches get a benefit from ( acetaminop­hen).”

A 2013 Cochrane review found the drug inferior to ibuprofen for reducing dental pain at all doses studied.

Perhaps most telling is a 2021 review that included 36 systematic studies of 44 painful conditions.

It concluded that acetaminop­hen provided modest pain relief for one of them, osteoarthr­itis of the hip and knee. There was no sound evidence of the drug’s ability to treat any other painful condition.

Yet now, some doctors give it intravenou­sly for postsurgic­al pain, a cruel and unethical practice if there ever was one.

The government promulgate­s an erroneous fear of opioids that makes patients often endure agonizing postoperat­ive pain that they never would have experience­d a decade ago, a violation of basic medical standards.

Doctors take an oath to ease suffering and do no harm

Yet, contrary to politician­s’ beliefs, data show that the addiction rate of medically used opioids has been about 1%. Government data also show no correlatio­n between the volume of opioids prescribed and the rate of abuse or addiction.

The treatment and management of acute and chronic pain involve the same nuanced medical decision- making as treating hypertensi­on, diabetes, infectious diseases and psychiatri­c disorders. Just as it is wrong for the government to dictate how doctors treat those conditions, it should butt out when doctors treat pain.

Doctors take an oath to ease suffering and do no harm. Government meddling is causing doctors to violate their profession­al credo.

Dr. Jeffrey A. Singer practices general surgery in Phoenix and is a senior fellow at the Cato Institute. Josh Bloom is director of chemical and pharmaceut­ical science at the American Council on Science and Health.

 ?? AP ?? Policymake­rs, driven by fear of opioids, have pressured doctors and hospitals to switch to acetaminop­hen, no matter how severe the pain, the authors write.
AP Policymake­rs, driven by fear of opioids, have pressured doctors and hospitals to switch to acetaminop­hen, no matter how severe the pain, the authors write.
 ?? ??
 ?? ??

Newspapers in English

Newspapers from United States